ZA200701188B - Use of C3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same - Google Patents

Use of C3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Info

Publication number
ZA200701188B
ZA200701188B ZA200701188A ZA200701188A ZA200701188B ZA 200701188 B ZA200701188 B ZA 200701188B ZA 200701188 A ZA200701188 A ZA 200701188A ZA 200701188 A ZA200701188 A ZA 200701188A ZA 200701188 B ZA200701188 B ZA 200701188B
Authority
ZA
South Africa
Prior art keywords
colorectal
carcinoma
biomarker
test system
ademona
Prior art date
Application number
ZA200701188A
Other languages
English (en)
Inventor
Juhl Hartmut
David Kerstin
Fentz Anne-Kristin
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200701188(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of ZA200701188B publication Critical patent/ZA200701188B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200701188A 2004-08-13 2005-08-11 Use of C3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same ZA200701188B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
ZA200701188B true ZA200701188B (en) 2009-01-28

Family

ID=34958684

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701188A ZA200701188B (en) 2004-08-13 2005-08-11 Use of C3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Country Status (20)

Country Link
US (2) US7951528B2 (xx)
EP (3) EP1761779B1 (xx)
JP (2) JP4916441B2 (xx)
KR (1) KR20070051328A (xx)
CN (2) CN101014859A (xx)
AT (2) ATE376674T1 (xx)
AU (2) AU2004322162B2 (xx)
BR (1) BRPI0419002A (xx)
CA (2) CA2577601A1 (xx)
DE (2) DE602004009716T2 (xx)
DK (2) DK1761779T3 (xx)
ES (2) ES2295907T3 (xx)
IL (2) IL181131A (xx)
MX (2) MX2007001479A (xx)
NO (2) NO20070598L (xx)
PL (2) PL1761779T3 (xx)
PT (2) PT1761779E (xx)
SI (1) SI1776587T1 (xx)
WO (2) WO2006015616A1 (xx)
ZA (1) ZA200701188B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1761779T3 (pl) 2004-08-13 2008-04-30 Indivumed Gmbh Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
JP5570810B2 (ja) * 2007-08-18 2014-08-13 学校法人北里研究所 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
EP2926138A4 (en) * 2012-11-30 2016-09-14 Applied Proteomics Inc METHOD FOR ASSESSING THE PRESENCE OR RISK OF COLON TUMORS
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
SG11201608053PA (en) * 2014-03-28 2016-10-28 Applied Proteomics Inc Protein biomarker profiles for detecting colorectal tumors
EP3183578B8 (en) * 2014-08-22 2020-07-15 Abbott Laboratories Methods for the early detection of colorectal cancer
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
US9689874B2 (en) 2015-04-10 2017-06-27 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
WO2002059621A2 (en) 2001-01-24 2002-08-01 Bayer Corporation Regulation of transthyretin to treat obesity
WO2003000182A2 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
WO2004001072A2 (en) 2002-06-19 2003-12-31 Oncotherapy Science, Inc. Method for diagnosis of colorectal tumors
US7605003B2 (en) 2002-08-06 2009-10-20 The Johns Hopkins University Use of biomarkers for detecting ovarian cancer
EP1895302A3 (en) * 2003-04-08 2008-05-14 Colotech A/S A method of detecting of colorectal cancer in human samples
US7268117B2 (en) * 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
BRPI0419004A (pt) 2004-08-13 2007-12-11 Egomedical Technologies Ag sistema de testes de analitos para determinar a concentração de um analito em um fluido fisiológico ou aquoso
PL1761779T3 (pl) 2004-08-13 2008-04-30 Indivumed Gmbh Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
IL181132A (en) 2011-04-28
IL181131A (en) 2011-03-31
DE602005012108D1 (de) 2009-02-12
AU2005306103A1 (en) 2006-05-26
IL181132A0 (en) 2007-07-04
KR20070051328A (ko) 2007-05-17
EP1776587B9 (en) 2009-09-16
US7883842B2 (en) 2011-02-08
EP1776587B1 (en) 2008-12-31
JP2008509409A (ja) 2008-03-27
SI1776587T1 (sl) 2009-06-30
CA2576998A1 (en) 2006-05-26
DE602004009716D1 (de) 2007-12-06
EP1843159A1 (en) 2007-10-10
CA2577601A1 (en) 2006-02-16
WO2006053592A1 (en) 2006-05-26
ES2322378T3 (es) 2009-06-19
WO2006015616A1 (en) 2006-02-16
NO20070598L (no) 2007-05-14
CN101014859A (zh) 2007-08-08
PL1776587T3 (pl) 2009-06-30
JP2008509407A (ja) 2008-03-27
MX2007001254A (es) 2007-10-05
US20070184499A1 (en) 2007-08-09
ES2295907T3 (es) 2008-04-16
PT1776587E (pt) 2009-04-03
BRPI0419002A (pt) 2007-12-11
US7951528B2 (en) 2011-05-31
EP1761779A1 (en) 2007-03-14
PT1761779E (pt) 2008-02-01
PL1761779T3 (pl) 2008-04-30
IL181131A0 (en) 2007-07-04
DK1776587T3 (da) 2009-04-20
CN101014861A (zh) 2007-08-08
DE602004009716T2 (de) 2008-08-28
AU2004322162A1 (en) 2006-02-16
US20080160515A1 (en) 2008-07-03
ATE419534T1 (de) 2009-01-15
EP1776587A1 (en) 2007-04-25
EP1761779B1 (en) 2007-10-24
JP4916441B2 (ja) 2012-04-11
AU2004322162A2 (en) 2006-02-16
MX2007001479A (es) 2007-07-25
DK1761779T3 (da) 2008-02-25
JP4592753B2 (ja) 2010-12-08
AU2004322162B2 (en) 2011-04-28
ATE376674T1 (de) 2007-11-15
NO20070599L (no) 2007-05-14

Similar Documents

Publication Publication Date Title
IL181131A0 (en) USE OF C3a AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADEMONA AND/OR CARCINOMA; DIAGNOSIS METHOD AND TEST SYSTEM USING THE SAME
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
NO20083820L (no) Deteksjon av kreft ved forhoyede nivaer av BCL-2
WO2007005666A3 (en) System and method of analyte detection using differential receptors
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
ECSP056124A (es) Método y dispositivo para detectar analitos volátiles en muestras de aire
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2004057336A3 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2007061940A3 (en) Method for detecting an inflammatory disease or cancer
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2003102015A3 (en) Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
WO2009063249A3 (en) Early detection of sepsis
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
EP1767646A4 (en) PROBE FOR DETECTING / DETERMINING INOSITOL-1,4,5-TRIPHOSPHORIC ACID AND PROCESS FOR DETERMINING / DETERMINING INOSITOL-1,4,5-TRIPHOSPHORIC ACID THEREWITH
WO2002000342A3 (en) Method and apparatus for performing an assay
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal
ZA200801176B (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system